(Q53121884)

English

Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

heparan sulfate proteoglycans

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Nikos K. Karamanos

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

author name string

Christina J Malavaki

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

Andreas E Roussidis

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

Chrisostomi Gialeli

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

Dimitris Kletsas

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

Theodore Tsegenidis

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

Achileas D Theocharis

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

George N Tzanakakis

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

language of work or name

0 references

publication date

27 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

280

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

2477-2489

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

c-kit and SCF expression in normal and tumor breast tissue

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

New members of the platelet-derived growth factor family of mitogens

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

The cystine-knot growth-factor superfamily

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

PDGF signaling in cells and mice

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Glycosaminoglycans and PDGF signaling in mesenchymal cells.

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Developmental roles of platelet-derived growth factors

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Regulation of PDGF and its receptors in fibrotic diseases

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

PDGF and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Proteoglycans in cancer biology, tumour microenvironment and angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Heparan sulfate proteoglycans in invasion and metastasis

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Complexity of the early genetic response to growth factors in mouse fibroblasts

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Tyrosine kinase inhibitor imatinib (STI571) as an anticancer agent for solid tumours

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Regulation of Raf-Akt Cross-talk

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer.

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

PDGF receptors as cancer drug targets

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

PDGF receptors as targets in tumor treatment

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Comprehensive dissection of PDGF-PDGFR signaling pathways in PDGFR genetically defined cells

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Proteoglycans in health and disease: the multiple roles of syndecan shedding

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Syndecans as receptors and organizers of the extracellular matrix

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells.

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation.

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12163

21 January 2018

Identifiers

10.1111/FEBS.12163

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23374223

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53121884&oldid=1584529396"